Over the past decade, biotechnology companies have increasingly turned to psychedelic substances like LSD and psilocybin (the active ingredient in magic mushrooms) to help their employees create new ideas and make big decisions. Studies suggest that hallucinogens allow people to re-evaluate situations from different perspectives, develop creative solutions, and feel more connected to their co-workers and families. Psychedelics like these also change how society thinks about how we treat mental illness, addiction, and creativity. This article explores how biotechnology companies are using psychedelics to change the business culture around the world.

What is biotechnology used for currently?

Currently, biotechnology is used to manufacture antibiotics, genetically modified organisms, and vaccines. But what about using biotechnology for something completely different? What would happen if we used technology to create a psychedelic experience instead of something practical like medicine or food? To answer that question, we need to look at how psychedelics work and examine human consciousness. Psychedelic drugs such as LSD, DMT and Psilocybin stimulate areas of your brain responsible for visual processing when you consume them. These drugs activate parts of your brain that don’t respond when you take pictures or look at art. Essentially, you can see things in your mind when on these drugs that you normally wouldn’t be able to without an outside influence. This excites certain sections of your brain, but it also has long-term effects on consciousness. It changes our natural perception, which allows us to improve our cognition over time. In fact, A few companies like Bright Mind Bio, a Canadian based 
biotechnology company, have begun exploring ways to modify plants with psychedelic molecules to grow stronger, more disease-resistant plants.

How psychedelics are improving current biotechnologies

Before you get excited, no, psychedelics won’t be curing cancer anytime soon. However, that doesn’t mean they can’t help improve current biotechnologies to treat disease and pain better. Researchers are studying how mind-altering substances can make patients feel more comfortable during less invasive medical procedures. Can you imagine getting your surgery while high on psilocybin? You probably shouldn’t—but it might work wonders for helping you get over your fear of needles. The same goes for transcranial magnetic stimulation (TMS), a non-invasive method of stimulating nerves in our brain without causing damage. When paired with psychedelics, TMS therapy seems to have incredible effects on people suffering from depression who haven’t responded well to other treatments.

New biotechs see practice-changing potential in psychedelics.

As pharmaceutical companies have begun to look for new avenues of treatment for conditions such as depression and addiction, several biotechs have started to focus on psychedelics. There is reason to believe that psilocybin can be used in general practice. In addition to being more affordable than currently available treatments, psilocybin has been found to have few side effects when taken in a controlled environment. What’s more, it appears to cause long-lasting positive behavioral changes after just one dose. It seems to make a positive effect on people's lives who are using it moderately.